Research Highlights and TTCI Internal Meeting Part I May 27, 2024 Member Content https://www.ttci-th.org/wp-content/uploads/2024/06/video1504702293.mp4 Continue Reading
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies May 1, 2024 Member Content Recorded VDO Continue Reading
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia April 3, 2024 Member Content Recorded VDO Continue Reading
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response February 28, 2024 Member Content Recorded VDO Continue Reading
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases February 28, 2024 Member Content Recorded VDO Continue Reading
Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo January 24, 2024 Member Content Recorded VDO Continue Reading
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells November 29, 2023 Member Content Recorded VDO Continue Reading
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy October 25, 2023 Member Content Recorded VDO Continue Reading
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy September 27, 2023 Member Content Recorded VDO Continue Reading
